Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 264 Glioma 109 Brain Neoplasms 104 Gliosarcoma 85 Central Nervous System Neoplasms 64 Astrocytoma 61 Melanoma 46 Oligodendroglioma 44 Neuroblastoma 28 Recurrence 22 Neoplasm Metastasis 18 Neoplasms 16 Medulloblastoma 16 Ependymoma 16 Sarcoma, Ewing 13 Lymphoma 13 Sarcoma 12 Rhabdomyosarcoma 11 Neuroendocrine Tumors 11 Lung Neoplasms 11 Diffuse Intrinsic Pontine Glioma 10 Small Cell Lung Carcinoma 9 Neuroectodermal Tumors, Primitive 7 Colorectal Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Osteosarcoma 6 Pinealoma 5 Optic Nerve Glioma 5 Choroid Plexus Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Cancer Recurrent × Temozolomide × Clear all

NCT02477813 2018-11-13

TeRes

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Small Cell Lung Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡